Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets.

Dong, Xingxing; Yang, Yalong; Hou, Jinxuan; Chen, Weizhen; Yuan, Qianqian; Xu, Gaoran; Liu, Jiuyang; Li, Chengxin; Wu, Gaosong

Dong, Xingxing; Yang, Yalong; Hou, Jinxuan; Chen, Weizhen; Yuan, Qianqian; Xu, Gaoran; Liu, Jiuyang; Li, Chengxin; Wu, Gaosong.

Afiliación

Dong X; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yang Y; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Hou J; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Chen W; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yuan Q; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xu G; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Liu J; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Li C; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wu G; Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Front Oncol ; 12: 1018479, 2022.

Article en En | MEDLINE | ID: mdl-36530988

Palabras clave

anaplastic thyroid carcinoma; enrichment analysis; immune checkpoint; therapeutic target; transcription factor; weighted gene co-expression network analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google